UNSPSC 85492039: Dilation of coronary artery, two sites, bifurcation, with drug-eluting intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of coronary artery, two sites, bifurcation, with drug-eluting intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 271446

UNSPSC 85492039 Dilation of coronary artery, two sites, bifurcation, with drug-eluting intraluminal device, percutaneous endoscopic approach is a Commodity code that shows no alignment between its nominal scope—a highly specific interventional cardiology procedure code—and the state and local opportunities recently posted under it. The recent solicitations span independent medical evaluation services for public safety pension disability determinations, surgical benefit carve-out programs for municipal employees, occupational medical surveillance for state ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing across multiple ancillary clinical categories. None of these opportunities involve coronary artery dilation procedures or the purchase of drug-eluting intraluminal devices; they represent general healthcare services procurement by public sector entities rather than acquisition of a specific interventional procedure or device.

The issuing bodies in the recent-opportunities block include city retirement offices (City of Phoenix), municipal human resources departments (City of Long Beach), state transportation agencies (Washington State Department of Transportation), county juvenile justice systems (Harris County), county procurement and benefits divisions (Collier County), and county health systems (County of Santa Clara). The geographic spread spans Arizona, California, Florida, Texas, and Washington. The code appears to carry a medical procedure classification that does not reflect actual state and local purchasing activity; vendors pursuing work under this code should verify with issuing bodies that the procedure code accurately describes their solicitation scope, as the mismatch between the code's clinical descriptor and the procurement opportunities posted suggests potential data-entry error or misalignment in the state or local procurement system tagging the opportunities.